University at Buffalo: Researchers Develop New Inhalable TB Treatment

10 February 2026

University at Buffalo press release

Researchers have developed a new inhalable form of TB treatment that could significantly reduce the burden of current therapy.

A study details the development of an inhalable, immunomodulating, biocompatible nanoparticle system encapsulating rifampin, one of the most important TB drugs.

Read the full press release here.

Source: University at Buffalo